Biogen Inc.

Biogen Inc. (BIIB) Price Prediction & Forecast

$235.350

+2.542 (+1.08%)At close

Price Predictions

1-Day Price Prediction
-1.11%
1-Week Prediction
-6.20%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Open in app to unlock longer-horizon forecasts.

Loading chart…

BIIB Prediction & Forecast by Similar Chart Analysis

Alphio's BIIB stock price prediction model matches the current Biogen Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $230.07 (-1.11%). The 1-week path is $218.23 (-6.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Should I Buy Biogen Inc. Stock?

Biogen Inc is a good buy right now due to its current price of $225.71, a strong forward P/E ratio of 13.947, and a significant year-to-date change of +26.93%. The recent RSI of 59.117 indicates bullish momentum, while the analyst price target suggests potential upside of 19.5% from the current price. However, the main risk is the insider selling activity, which has increased by 864.10% over the last month, indicating possible concerns among insiders.

BIIB stock price ended at $235.35 on Thursday, after rising +1.08%

Biogen Inc. (BIIB) last closed at $232.65, losing -1.15%. These facts feed the 1-day and 1-week BIIB price prediction above.

Analyst Consensus

Biogen Inc. (BIIB): 21 buy, 11 hold, 0 sell. Outlook: Buy.

Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.

Strong sellSellNeutralBuyStrong buy
Strong buy
Sell
0
Buy
21

Forecast Drivers

Biogen Inc. (BIIB) forecast drivers combine similar chart patterns, seasonality, and moving averages.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Positive

Bullish

SMA 200

Positive

Bullish

Similar Chart Patterns

Stocks whose recent price path most closely matches BIIB, ranked by similarity.

Seasonality analysis for BIIB

Historically the probability of a positive October return for BIIB is 36.21%. December offers the highest probability of a positive month at 51.16%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

10-year price projections for BIIB

MonthMin PriceAvg PriceMax PricePotential ROI
Oct 2026$136.73$148.01$176.10-36.38%
Nov 2026$123.38$140.16$145.02-39.75%
Dec 2026$110.12$110.77$140.81-52.39%

In 2026, Biogen Inc. (BIIB) is projected to range from $110.12 to $176.10.

Biogen Inc. 2026 monthly forecast

Oct 2026 BIIB forecast
Potential ROI: -36.38%

In Oct 2026, Biogen Inc. is projected to average $148.01, with a low of $136.73 and high of $176.10.

Nov 2026 BIIB forecast
Potential ROI: -39.75%

In Nov 2026, Biogen Inc. is projected to average $140.16, with a low of $123.38 and high of $145.02.

Dec 2026 BIIB forecast
Potential ROI: -52.39%

In Dec 2026, Biogen Inc. is projected to average $110.77, with a low of $110.12 and high of $140.81.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading